PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Over-reliance of pulse oximetry for children with respiratory infection

2014-08-19
(Press-News.org) Among infants presenting to a pediatric emergency department with mild to moderate bronchiolitis, those with an artificially elevated oxygen saturation reading were less likely to be hospitalized or receive hospital care for more than 6 hours than those with unaltered readings, suggesting that these readings should not be the only factor in the decision to admit or discharge, according to a study in the August 20 issue of JAMA.

Bronchiolitis, a viral lower respiratory tract infection, is the leading cause of infant hospitalizations in the United States, with annual costs in excess of $1 billion. Between 1980 and 2000, the rate of hospitalizations for bronchiolitis more than doubled. Pulse oximetry, which involves an instrument usually attached on the finger or ear lobe, is a noninvasive method of measuring oxygen saturation, and its routine use has been associated with changes in the management of bronchiolitis. There is no evidence that certain cutoff measurements predict progression from relatively mild to severe bronchiolitis, according to background information in the article. "If well-appearing children with mild to moderate bronchiolitis can be sent home, fewer hospitalizations and lower health care costs could result."

Suzanne Schuh, M.D., F.R.C.P.C., of The Hospital for Sick Children, Toronto, and colleagues conducted a randomized clinical trial to determine if increasing the displayed oximetry reading three percentage points above the true values would decrease the probability of hospitalization within 72 hours or hospital care for greater than 6 hours. The study included 213 otherwise healthy infants 4 weeks to 12 months of age with mild to moderate bronchiolitis in a tertiary-care pediatric emergency department in Toronto.

The researchers found that 41 percent (44/108) of children in the true oximetry group were hospitalized within 72 hours, compared with 25 percent (26/105) in the altered oximetry group. There were 23 of 108 (21.3 percent) subsequent unscheduled medical visits for bronchiolitis in the true oximetry group and 15 of 105 (14.3 percent) in the altered oximetry group.

"Artificially increasing the oximetry display in emergency department patients with mild to moderate bronchiolitis by a physiologically small amount significantly reduced hospitalizations within 72 hours or active hospital care for more than 6 hours compared with infants with unaltered oximetry readings. This conclusion also held true after adjustment for other variables significantly associated with this outcome. Because the groups had similar severity and the adjustment for the experimental saturation resulted in lack of primary treatment effect, the difference in displayed saturations was likely the primary reason for the observed reduction in hospitalizations," the authors write.

The researchers add that these findings suggest "that oxygen saturation should not be the only factor in the decision to admit, and its use may need to be re-evaluated."

(doi:10.1001/jama.2014.8637; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Bronchiolitis, Deception in Research, and Clinical Decision Making

In an accompanying editorial, Robert Vinci, M.D., of the Boston University School of Medicine, and Howard Bauchner, M.D., Editor in Chief, JAMA, comment on the findings of this study.

"… it is now clear that the oxygen saturation reading can influence decision making in ways that many clinicians have thought likely—overreliance on physiologic information of uncertain importance derived from a medical device. While physicians seek to improve the science of clinical decision making, the art of medicine and clinical assessment should not be trumped by overreliance on a single physiologic parameter. The care of patients with bronchiolitis will continue to improve as experienced physicians emphasize and continue to use a complete clinical evaluation and assessment as the most important element in the care of these infants and children."

(doi:10.1001/jama.2014.8638; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Study examines incidence, survival rate of severe immunodeficiency disorder in newborns

2014-08-19
Newborn screening performed in numerous states indicates that the incidence of the potentially life-threatening disorder, severe combined immunodeficiency, is higher than previously believed, at 1 in 58,000 births, although there is a high rate of survival, according to a study in the August 20 issue of JAMA. The purpose of newborn screening is early detection of inborn conditions for which prompt treatments can reduce the risk of death or irreversible damage. The first heritable immune disorders to which newborn screening has been applied are those that together comprise ...

Prevalence of HSV type 2 decreases among pregnant women in the Pacific Northwest

2014-08-19
In a study that included approximately 15,000 pregnant women, seroprevalence of herpes simplex virus (HSV) type 2 decreased substantially between 1989 and 2010 while there was no overall decrease for HSV type 1, but a slight increase among black women, according to a study in the August 20 issue of JAMA. Shani Delaney, M.D., and Anna Wald, M.D., M.P.H., of the University of Washington, Seattle, and colleagues examined trends in the seroprevalence of HSV-1 and HSV-2 among pregnant women who delivered newborns at the University of Washington Medical Center between January ...

UCSF-led study finds SCID previously underdiagnosed in infants with fatal infections

2014-08-19
Severe combined immunodeficiency (SCID), a potentially life-threatening, but treatable, disorder affecting infants, is twice as common as previously believed, according to a new study that is the first to examine the national impact of this newborn screening test. The study is the first combined analysis of more than 3 million infants screened for SCID in 10 states and the Navajo Nation. Infants from participating programs born from the start of the first pilot program in January 2008 through July 2013 were included. In May, 2010, SCID was the 29th condition added ...

In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome

2014-08-19
(Boston) – Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood. While genetic and epigenetic (when genes are turned on or off) changes have recently been identified as potential factors, researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) conducted a first of its kind study to identify some of these epigenetic changes that may influence symptom severity. The researchers focused ...

Novel oral anticoagulant prescriptions soar, but at a high cost

2014-08-19
Philadelphia, PA, August 19, 2014 – Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid adoption of these novel oral anticoagulants (NOACs) into clinical practice. By mid-2013 NOACs accounted for 62% of all new anticoagulant prescriptions yet this represents 98% of total anticoagulant-related drug costs. Findings are published in The American Journal of Medicine. Atrial fibrillation (AF) is a serious ...

Markey researchers develop web-based app to predict glioma mutations

Markey researchers develop web-based app to predict glioma mutations
2014-08-19
new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require testing for a genetic mutation. Gliomas – a type of tumor that begins in the brain or spine – are the most common and deadly form of brain cancer in adults, making up about 80 percent of malignant brain cancer cases. In some of these cases, patients have a mutation in a specific gene, known as an IDH1 mutation – and patients who have this tend to survive years longer than those ...

Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety

Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety
2014-08-19
LAWRENCE — It's not a monkey. It's not a lemur. It's not an African Bush Baby or even a Madagascan Mouse. Meet the Philippine tarsier: a tiny, adorable and downright "cool" primate from Southeast Asia. "It's really not like any animals that Americans are familiar with," said Rafe Brown, curator-in-charge at the University of Kansas' Biodiversity Institute. "A tarsier has giant eyes and ears; an extremely cute, furry body; a long tail with a furry tuft at the end; and interesting expanded fingers and toe tips that look a bit like the disks on the digits of tree frogs." Brown ...

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
2014-08-19
In many parts of the world, leprosy and tuberculosis live side-by-side. Worldwide there are approximately 233,000 new cases of leprosy per year, with nearly all of them occurring where tuberculosis is endemic. The currently available century-old vaccine Bacille Calmette-Guerin, or BCG, provides only partial protection against both tuberculosis and leprosy, so a more potent vaccine is needed to combat both diseases. UCLA-led research may have found a stronger weapon against both diseases. In a study published in the September issue of the peer-reviewed journal Infection ...

Seafood substitutions can expose consumers to unexpectedly high mercury

2014-08-19
New measurements from fish purchased at retail seafood counters in 10 different states show the extent to which mislabeling can expose consumers to unexpectedly high levels of mercury, a harmful pollutant. Fishery stock "substitutions"—which falsely present a fish of the same species, but from a different geographic origin—are the most dangerous mislabeling offense, according to new research by University of Hawai'i at Mānoa scientists. "Accurate labeling of seafood is essential to allow consumers to choose sustainable fisheries," said UH Mānoa biologist Peter ...

Engineering new bone growth

2014-08-19
CAMBRIDGE, MA -- MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated scaffold induces the body to rapidly form new bone that looks and behaves just like the original tissue. This type of coated scaffold could offer a dramatic improvement over the current standard for treating bone injuries, which involves transplanting bone from another part of the patient's body — a painful process that does not always supply enough bone. ...

LAST 30 PRESS RELEASES:

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

[Press-News.org] Over-reliance of pulse oximetry for children with respiratory infection